These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2062 related articles for article (PubMed ID: 24410438)
1. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of hyaluronic acid decorated PLGA nanoparticles for delivery of 5-fluorouracil. Yadav AK; Agarwal A; Rai G; Mishra P; Jain S; Mishra AK; Agrawal H; Agrawal GP Drug Deliv; 2010 Nov; 17(8):561-72. PubMed ID: 20738221 [TBL] [Abstract][Full Text] [Related]
3. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies. Li X; Xu Y; Chen G; Wei P; Ping Q Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762 [TBL] [Abstract][Full Text] [Related]
4. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma. Srivastava S; Gupta S; Mohammad S; Ahmad I J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208 [TBL] [Abstract][Full Text] [Related]
5. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer. Sun B; Ranganathan B; Feng SS Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985 [TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926 [TBL] [Abstract][Full Text] [Related]
8. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS; Mei L; Anitha P; Gan CW; Zhou W Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012 [TBL] [Abstract][Full Text] [Related]
9. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery. Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433 [TBL] [Abstract][Full Text] [Related]
10. Peripheral benzodiazepine receptor ligand-PLGA polymer conjugates potentially useful as delivery systems of apoptotic agents. Laquintana V; Denora N; Musacchio T; Lasorsa M; Latrofa A; Trapani G J Control Release; 2009 Aug; 137(3):185-95. PubMed ID: 19374931 [TBL] [Abstract][Full Text] [Related]
11. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies. Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973 [TBL] [Abstract][Full Text] [Related]
12. Development of sulfadiazine-decorated PLGA nanoparticles loaded with 5-fluorouracil and cell viability. Guimarães PP; Oliveira SR; de Castro Rodrigues G; Gontijo SM; Lula IS; Cortés ME; Denadai ÂM; Sinisterra RD Molecules; 2015 Jan; 20(1):879-99. PubMed ID: 25580685 [TBL] [Abstract][Full Text] [Related]
13. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574 [TBL] [Abstract][Full Text] [Related]
14. Targeting liver cancer via ASGP receptor using 5-FU-loaded surface-modified PLGA nanoparticles. Dangi R; Hurkat P; Jain A; Shilpi S; Jain A; Gulbake A; Jain SK J Microencapsul; 2014; 31(5):479-87. PubMed ID: 24697169 [TBL] [Abstract][Full Text] [Related]
15. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels. Lopalco A; Cutrignelli A; Denora N; Perrone M; Iacobazzi RM; Fanizza E; Lopedota A; Depalo N; de Candia M; Franco M; Laquintana V Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641449 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells loaded with paclitaxel-poly(lactic- Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710 [TBL] [Abstract][Full Text] [Related]
17. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications. Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353 [TBL] [Abstract][Full Text] [Related]
18. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867 [TBL] [Abstract][Full Text] [Related]
19. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cytotoxic effects of PLGA coated iron oxide nanoparticles as a carrier of 5- fluorouracil and mega-voltage X-ray radiation in DU145 prostate cancer cell line. Hajikarimi Z; Khoei S; Khoee S; Mahdavi SR IEEE Trans Nanobioscience; 2014 Dec; 13(4):403-8. PubMed ID: 25051558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]